Julieta Grasselli

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

Julieta Grasselli, Élena Elez, Ginevra Caratù et al. · Annals of Oncology · 2017 · 189 citations · Full text

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in <i>BRAF</i> -Mutant Colorectal Cancer

Daniele Oddo, Erin M. Sennott, Ludovic Barault et al. · Cancer Research · 2016 · 119 citations · Full text

Impact of circulating tumor DNA mutant allele fraction on prognosis in <i>RAS</i>‐mutant metastatic colorectal cancer

Élena Elez, Chiara Chianese, Enrique Sanz‐García et al. · Molecular Oncology · 2019 · 52 citations · Full text

TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer

Paula Vázquez, María J. Carlini, María Cecilia Daroqui et al. · Clinical & Experimental Metastasis · 2013 · 32 citations · Full text

Oncology, Murine Lung Adenocarcinoma, Medicine +8